Hirtle Callaghan & Co’s Progyny PGNY Stock Holding History

Hirtle Callaghan & Co’s Portfolio PGNY Stock Details PGNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,390	Closed	-$277K	–	136
2022 Q1	$277K	Buy	+5,390	New	+$231K	0.01%	113

Other funds holding PGNY

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hirtle Callaghan & Co's PGNY Position: Q2 2022 in Review

Hirtle Callaghan & Co sold out of Progyny (PGNY) in Q2 2022, closing a stake of 5,390 shares — an estimated $277K sold.

Hirtle Callaghan & Co first reported a position in PGNY in Q1 2022 and held it in 1 quarter. The position peaked at $277K in Q1 2022. 247 funds tracked by Wall St. Rank hold PGNY as of Q2 2022.

Hirtle Callaghan & Co reported no remaining Progyny position as of Q2 2022 after selling out during the quarter.
Hirtle Callaghan & Co sold 5,390 Progyny shares in Q2 2022, an estimated $277K.
Hirtle Callaghan & Co first reported a position in Progyny in Q1 2022 and held it in 1 quarter.
Hirtle Callaghan & Co's Progyny position peaked at $277K in Q1 2022.
247 funds tracked by Wall St. Rank held Progyny as of Q2 2022.

Based on Hirtle Callaghan & Co's 13F filing for Q2 2022, filed 15 Aug 2022.